Cargando…
Neuroprotection by Exendin-4 Is GLP-1 Receptor Specific but DA D(3) Receptor Dependent, Causing Altered BrdU Incorporation in Subventricular Zone and Substantia Nigra
Glucagon-like peptide-1 receptor (GLP-1R) activation by exendin-4 (EX-4) is effective in preclinical models of Parkinson's disease (PD) and appears to promote neurogenesis even in severely lesioned rats. In the present study, we determined the effects of EX-4 on cellular BrdU incorporation in t...
Autores principales: | Harkavyi, A., Rampersaud, N., Whitton, P. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437329/ https://www.ncbi.nlm.nih.gov/pubmed/26316987 http://dx.doi.org/10.1155/2013/407152 |
Ejemplares similares
-
Detection and Quantification of Retinal Neovascularization Using BrdU Incorporation
por: Shao, Yan, et al.
Publicado: (2020) -
Urocortin, a CRF-like peptide, restores key indicators of damage in the substantia nigra in a neuroinflammatory model of Parkinson's disease
por: Abuirmeileh, Amjad, et al.
Publicado: (2007) -
Effects of tumour necrosis factor-α on BrdU incorporation in cultured human enterocytes
por: McDevitt, J., et al.
Publicado: (1995) -
Unexpected BrdU inhibition on astrocyte-to-neuron conversion
por: Wang, Tao, et al.
Publicado: (2021) -
Contrasting activity patterns determined by BrdU incorporation in bacterial ribotypes from the Arctic Ocean in winter
por: Galand, Pierre E., et al.
Publicado: (2013)